NASDAQ:OBSV

ObsEva SEC Filings & 10K Form

$2.52
-0.07 (-2.70 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.49
$2.60
50-Day Range
$2.47
$3.19
52-Week Range
$1.86
$5.55
Volume1.61 million shs
Average Volume4.10 million shs
Market Capitalization$145.03 million
P/E RatioN/A
Dividend YieldN/A
Beta0.76

ObsEva (NASDAQ:OBSV) SEC Filings

DateFilerForm TypeView
07/27/2021
5:12 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2021
5:30 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/25/2021
4:22 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2021
5:30 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2021
5:05 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2021
5:03 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2021
5:31 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2021
6:15 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2021
7:15 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2021
6:55 AM
ObsEva (Filer)
Form 424B5
03/05/2021
6:21 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2021
5:04 AM
ObsEva (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/04/2021
5:13 AM
ObsEva (Subject)
Sofinnova Venture Partners VIII, L.P. (Filed by)
Form SC 13D/A
02/17/2021
5:04 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2021
3:58 PM
ARMISTICE CAPITAL, LLC (Filed by)
ObsEva (Subject)
Form SC 13G/A
02/11/2021
9:27 AM
Medicxi Growth I LP (Filed by)
ObsEva (Subject)
Form SC 13G/A
02/11/2021
5:08 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2021
5:10 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2021
3:26 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2021
3:00 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/11/2021
6:05 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/04/2021
5:36 AM
ObsEva (Filer)
Form 6-K/A
01/04/2021
5:36 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2020
5:03 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2020
5:03 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/16/2020
5:39 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2020
6:32 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2020
5:02 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/13/2020
3:16 PM
ObsEva (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/14/2020
3:45 PM
ARMISTICE CAPITAL, LLC (Filed by)
ObsEva (Subject)
Form SC 13G
09/08/2020
6:40 AM
ObsEva (Filer)
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/08/2020
6:31 AM
ObsEva (Filer)
Form 424B5
08/14/2020
3:24 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/06/2020
5:53 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/07/2020
2:39 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2020
5:18 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2020
5:15 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2020
5:11 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2020
5:01 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2020
3:00 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/14/2020
5:41 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/07/2020
4:30 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/06/2020
3:00 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2020
6:19 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2020
3:10 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2020
5:21 AM
ObsEva (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
01/15/2020
7:35 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2019
8:11 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2019
3:21 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2019
7:16 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2019
7:27 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2019
11:15 PM
ObsEva (Filer)
Form EFFECT
08/09/2019
2:22 PM
ObsEva (Filer)
Form 6-K/A
08/07/2019
3:18 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2019
7:24 AM
ObsEva (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
08/07/2019
7:18 AM
ObsEva (Filer)
Form 424B5
08/07/2019
6:21 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2019
5:04 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2019
3:05 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/05/2019
5:01 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/19/2019
3:30 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2019
4:28 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/09/2019
5:05 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2019
3:05 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2019
5:12 AM
ObsEva (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/14/2019
3:27 PM
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
ObsEva (Subject)
Form SC 13G/A
02/14/2019
10:38 AM
ObsEva (Subject)
Sofinnova Capital VII FCPR (Filed by)
Form SC 13G/A
02/12/2019
3:02 PM
Loumaye Ernest (Filed by)
ObsEva (Subject)
Form SC 13G/A
11/08/2018
8:28 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2018
3:42 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/05/2018
1:04 PM
ObsEva (Subject)
Sofinnova Capital VII FCPR (Filed by)
Form SC 13G/A
10/03/2018
8:07 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/28/2018
7:40 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2018
6:00 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2018
7:21 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2018
6:42 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/22/2018
3:06 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2018
4:32 PM
ObsEva (Filer)
Form 424B5
06/18/2018
8:15 PM
ObsEva (Filer)
Form 424B5
06/18/2018
8:17 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2018
3:56 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2018
5:46 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2018
4:02 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/16/2018
8:46 PM
ObsEva (Filer)
Form 424B5
03/16/2018
8:40 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/09/2018
4:15 PM
ObsEva (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/07/2018
11:15 PM
ObsEva (Filer)
Form EFFECT
03/04/2018
11:15 PM
ObsEva (Filer)
Form EFFECT
03/01/2018
9:20 AM
ObsEva (Filer)
Form F-3/A
02/26/2018
4:12 PM
ObsEva (Filer)
Form 424B3
02/26/2018
4:07 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2018
10:42 AM
ObsEva (Filer)
Form F-3/A
02/14/2018
3:02 PM
Loumaye Ernest (Filed by)
ObsEva (Subject)
Form SC 13G
02/14/2018
2:01 PM
ObsEva (Subject)
Sofinnova Capital VII FCPR (Filed by)
Form SC 13G
02/13/2018
3:46 PM
ObsEva (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/01/2018
4:14 PM
ObsEva (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G
02/01/2018
4:11 PM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2018
4:06 PM
ObsEva (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/22/2018
4:12 PM
Ares Trading S.A. (Filed by)
ObsEva (Subject)
Form SC 13G/A
01/05/2018
7:00 AM
ObsEva (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.